Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease

Archives of Neurology

Volumn 58, Issue 3, 2001, Pages 487-492

  Ho, L ^a   Purohit, D ^a   Haroutunian, V ^a   Luterman, J D ^a   Willis, F ^a   Naslund, J ^a   Buxbaum, J D ^a   Mohs, R C ^a   Aisen, P S ^a   Pasinetti, G M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CADAVER; COGNITION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RATING SCALE; REGULATORY MECHANISM;

EID: 0035100231     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.3.487     Document Type: Article

References (18)

1. Clinical trial of indomethacin in Alzheimer's disease
2. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
3. Risk of Alzheimer's disease and duration of NSAID use
4. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
5. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain
6. Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease
7. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: Specific localization in affected neurons and axons
8. Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNA and proteins in human brain and peripheral organs
9. Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2
10. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease
11. The Clinical Dementia Rating (CDR): Current version and scoring rules
12. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: A commentary
13. A comparative study of modified Bielschowsky. Bodian and thioflavin S stain on Alzheimer's neurofibrillary tangles
14. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline
15. Cyclooxygenase and inflammation in Alzheimer's disease: Experimental approaches and clinical interventions
16. A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease
17. Neuropathological background of twenty-seven centenarian brains